Improve Patient Pain
Control Ratings

Higher overall patient satisfaction^1-5

DepoDur resulted in significantly more patients rating pain control as "very good" at 48 hours vs conventional epidural MS* injection3,13

Pain control was significantly better compared to IV PCA† fentanyl alone at 24 and 48 hours following major surgery1

* Morphine sulfate.
†Intravenous patient-controlled analgesia.

Important Safety Information

DepoDur is not intended for intrathecal, intravenous, or intramuscular administration. Administration of DepoDur into the thoracic epidural space or higher has not been evaluated and therefore is not recommended. The majority of adverse events were typical opioid-related side effects and would be expected in the surgical populations studied. No statistically significant differences between treatment groups with respect to nausea, pruritus, sedation scores, vomiting episodes, or urinary retention.   

More information on safety page.

Please see full Prescribing Information.